Clinical Trial Update: Leflunomide in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating leflunomide in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide (Leflunomide)

Snippet

Sponsor: Sanofi | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED